Study Title: Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling
Citation: Ortiz-Vilchis et al., 2014 · European Journal of Pharmacology
What the Study Found: Co-administration of (−)-epicatechin and doxycycline synergistically reduced infarct size in an ischemia-reperfusion model. The protective effect was mediated by inhibition of mitochondrial swelling. The combination preserved mitochondrial structure and function during reperfusion stress.
What this means in real life: During a heart attack, mitochondria swell and rupture, releasing signals that enlarge the damaged area. This study shows that (−)-epicatechin (especially when paired with doxycycline) powerfully prevents that swelling, limiting injury and preserving cellular energy capacity. Mitochondrial support is therefore a key strategy for protecting the heart when it faces sudden high-stress events like ischemia-reperfusion.
Contenu associé
- Want to understand how mitochondrial health protects the heart under stress? → 4 Risk Factors for Heart Disease and How to Improve Them Through a Better Understanding of Cellular Energy
- Want to understand how mitochondrial health protects the heart under sudden stress? → 7 Signs Your Heart Is Working Too Hard
- Looking to protect your cardiovascular system at the cellular level? → Mitozz: A New Era in Cellular Energy